Hematological features of patients with type 2 diabetes depending on the variant of SARS-COV-2
Fiziologichnyi Zhurnal
; 69(1):35-42, 2023.
Article
in English
| Scopus | ID: covidwho-20241251
ABSTRACT
The aim of our work was to investigate the peculiarities of hematological indicators in patients with COVID-19 depending on the variant of SARS-CoV-2. A retrospective study of the electronic medical records of 19 patients with the delta variant (7 patients had comorbidity with type 2 diabetes (T2D);12 patients without T2D - control group) and 46 patients with the omicron variant (26 patients had comorbidity with T2D;20 patients without T2D - control group). No statistically significant differences were found in gender, the number of leukocytes, lymphocytes, and granulocytes in peripheral blood, C-reactive protein, and D-dimer. The results also showed a significant difference in procalcitonin level and monocyte count in patients with delta variant and T2D. A predictive model was developed using binary logistic regression to determine the SARS-CoV-2 variant based on hematological parameters (sensitivity - 76.5%, specificity - 84.8%). Thus, the peculiarities of hematological indicators of patients with T2D depending on the variant of SARS-CoV-2 (delta or omicron) were established. © P. Petakh, K. Loshak, A. Kamyshnyi.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Variants
Language:
English
Journal:
Fiziologichnyi Zhurnal
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS